RCEL
AVITA Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$16.34
+6.57%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 502.77x
- P/S forward
- 4.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -18.15x
- Price / sales
- 6.68x
- Price / cash flow
- -20.86x
Enterprise value
- Enterprise value
- $542.6M
- EV / sales
- 7.17x
- EV / EBITDA
- -15.43x
- EV / EBIT
- -15.41x
- Market cap
- $505.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026